Minority News
The world you see depends upon the news you get. ®
May 18, 2024
University of Phoenix Leadership Joins Proceedings of 2024 PESC-A4L Spring Summit   •     •   Historic Inaugural Class Graduates from OSU College of Osteopathic Medicine at the Cherokee Nation   •     •   Sacred Heart Celebrates 125th Anniversary   •     •   Atlantic Coast Aesthetics Posts New 'Ask Dr. Pane' Blog and Video about a Mommy Makeover Procedure   •     •   Energy Vault Holdings, Inc. Announces Inducement Grants Under NYSE Listing Rule 303A.08   •     •   Rockwell Institute Celebrates Highest Real Estate Exam Pass Rates for First-Time Test Takers in the State of Washington   •     •   Federal, provincial and territorial ministers gather to support culture and heritage at annual meeting   •     •   Angels Helpers NYC 2024 Charity Gala Raises Funds for Harlem School of the Arts, Highbridge Voices   •     •   L.A. Care and Blue Shield of California Promise Health Plans Unveil New, Vibrant Community Resource Center in Panorama City with  •     •   Upneeq® Wins 2024 Shape Skin Award, “Best for Lift”, in the Professional Treatment Category   •     •   WOMEN'S HEALTHCARE COMPANY WATKINS-CONTI RECEIVES FDA 510(K) CLEARANCE FOR NEW STRESS URINARY INCONTINENCE DEVICE YŌNI.FIT&  •     •   4th-12th graders from Illinois excel at MathCON 2024 Finals   •     •   4th-12th graders from California excel at MathCON 2024 Finals   •     •   Aramco and Spiritus to Advance Direct Air Capture Technology, Investment by Aramco Ventures   •     •   Avangrid to Be Acquired by Iberdrola   •     •   Xylem Inc. Declares Second Quarter Dividend of 36 Cents per Share   •     •   The AZEK Company Receives NYSE Notice Regarding Filing of Form 10-Q for the Fiscal Quarter Ended March 31, 2024   •     •   4th-12th graders from New York excel at MathCON 2024 Finals   •     •   May and Stanley Smith Charitable Trust Partners with American Indian College Fund to Support Native Student Veterans   •     •   HERImpact: Entrepreneurship for Impact Program Kicks Off in Chicago, Empowering Women Entrepreneurs   •  
HOME SEARCH SUBSCRIBE CONTACT

AHF Backs FTC Challenge to Big Pharma Junk Patents

LOS ANGELES , May 03 /Businesswire/ - AIDS Healthcare Foundation (AHF) voiced support for the U.S. Federal Trade Commission (FTC) taking action this week to challenge several major pharmaceutical companies, including GSK, for anticompetitive use of so-called junk patents that prevent generic competition and keep drug prices artificially high.

“Big pharma is abusing the patent system by filing multiple derivative patents on existing drugs – which is not innovation – it’s greed. They pull every trick in the book to extend lucrative monopolies on a wide range of treatments for HIV, diabetes, asthma, weight loss, and more, and the public is left paying the bill,” said AHF President Michael Weinstein. “We applaud the FTC and the Biden administration for scrutinizing these practices to protect public health and ensure affordable access to vital medicines in the United States.”

Around the world, GSK has kept several middle-income countries, including Colombia and Trinidad and Tobago, from accessing generic versions of the HIV drug dolutegravir by leveraging their patent monopoly to force the countries to purchase the GSK-branded version of the drug at a much higher cost. AHF has worked closely with civil society partners to address these abuses.

In a big win for HIV treatment access advocates, Colombia recently issued a compulsory license on dolutegravir, which will allow it to treat as many as 27 people with generics for the cost of one branded regimen.

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.9 million clients in 47 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare